Boehringer Ingelheim
Metformin (500mg) + Linagliptin (2.5mg)
Trajenta Duo 2.5mg/500mg Tablet is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus.
Tablet
Trajenta Duo 2.5mg/500mg Tablet is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus. This helps prevent serious complications of diabetes such as kidney damage and blindness and may reduce your chance of having a heart attack or stroke.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Trajenta Duo 2.5mg/500mg Tablet is to be taken with food.
Trajenta Duo 2.5mg/500mg Tablet is a combination of two antidiabetic medicines:
Trajenta Duo 2.5mg/500mg Tablet should be taken with food to lower the chances of having an upset stomach. Take it in addition to regular exercise and a healthy diet to lower the levels of blood sugar. Chances of weight gain and low blood sugar are lesser as compared to other diabetes medicines. Hypoglycemia (low blood sugar level) may occur when taken along with other antidiabetic medicines Monitor your blood sugar level regularly while you are taking this medicine.
Yes, the use of Trajenta Duo 2.5mg/500mg Tablet can lead to a rare side effect called lactic acidosis (also known as Metformin-associated lactic acidosis). It is characterized by increased levels of lactic acid in the blood. This condition may occur in patients with underlying kidney disease, elderly patients, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, tiredness, feeling cold in arms and legs, difficulty breathing, nausea, vomiting, stomach pain, or slow heart rate. If you experience these symptoms, stop taking Trajenta Duo 2.5mg/500mg Tablet and consult your doctor immediately.
Common side effects associated with the use of Trajenta Duo 2.5mg/500mg Tablet include hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, and headache. Additionally, long-term use may lead to a rare but serious condition known as lactic acidosis.
The use of Trajenta Duo 2.5mg/500mg Tablet is contraindicated in patients with known allergy to any component of this medicine. It should also be avoided in individuals with severe kidney impairment, liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
No, consuming alcohol while taking Trajenta Duo 2.5mg/500mg Tablet increases the risk of lactic acidosis, especially in cases of fasting, malnutrition, or kidney dysfunction. If unsure, consult your doctor.
Store Trajenta Duo 2.5mg/500mg Tablet in its original packaging, tightly closed, according to the label or pack instructions. Dispose of unused medicine properly, ensuring it is not consumed by pets, children, or other individuals.
Trajenta Duo 2.5mg/500mg Tablet itself does not usually cause low blood sugar levels (hypoglycemia). However, it may occur if insufficient calories are consumed while taking this medicine. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regular monitoring of blood sugar levels is essential to prevent hypoglycemia.
Long-term use of Trajenta Duo 2.5mg/500mg Tablet may cause vitamin B12 deficiency due to interference with stomach absorption. Untreated deficiency can result in anemia, nerve problems, and other symptoms like a tingling sensation and numbness in hands and feet, weakness, urinary issues, changes in mental status, and difficulty maintaining balance (ataxia). Consult your doctor if you experience these symptoms.